The US Food and Drug Administration has issued updated guidance for companies that plan to adapt their Covid-19 medical products -- including vaccines, tests and therapeutics -- to address the emergence of coronavirus variants.
//google call
The US Food and Drug Administration has issued updated guidance for companies that plan to adapt their Covid-19 medical products -- including vaccines, tests and therapeutics -- to address the emergence of coronavirus variants.
0 comments:
Post a Comment